By Norma Erickson and Stephen Tunley In a recent article in Infectious Disease News[1]commenting on the research published in the latest issue of Lancet Oncology[2], Jason Harris reported: “There were 27 diagnosed HPV-related anal cancers in the vaccine group vs. 85 diagnoses in the control group, for a vaccine efficacy of 68.2% (95%GI, 51.4-79.7). For […]